felin
infecti
periton
fip
fatal
immunemedi
diseas
cat
induc
felin
coronaviru
fcov
combin
yet
poorli
understood
host
viral
factor
combin
caus
minor
fcovinfect
cat
develop
fip
clinicopatholog
featur
includ
fever
vascul
seros
without
effus
indic
proinflammatori
state
cytokin
releas
result
primari
immun
organ
well
circul
leukocyt
thu
far
interest
previou
studi
determin
like
sourc
cytokin
result
suggest
tissu
alon
may
suffici
induc
observ
inflamm
current
studi
therefor
focuss
liver
heart
organ
demonstr
abil
produc
cytokin
therefor
huge
potenti
exacerb
inflammatori
process
ratio
marker
immun
system
inflammatori
balanc
skew
toward
proinflammatori
liver
cat
fip
organ
found
upregul
mrna
express
inflammatori
triad
cytokin
fip
amplifi
step
may
one
miss
link
pathogenesi
enigmat
diseas
distribut
organ
lesion
develop
fip
lesion
trigger
activ
viru
infect
monocyt
presenc
generalis
activ
venou
endotheli
cell
monocyt
induc
granulomat
phlebiti
consid
first
hallmark
lesion
occur
rang
organ
endotheli
cell
activ
togeth
system
chang
fever
indic
excess
system
cytokin
releas
though
precis
sourc
remain
unclear
proinflammatori
cytokin
main
mediat
innat
immun
respons
allow
commun
prime
variou
compon
innat
immun
system
eg
activ
leukocyt
endotheli
cell
review
cat
interleukin
il
tumour
necrosi
factor
tnf
main
mediat
acut
phase
inflammatori
respons
cat
fip
exhibit
clear
clinic
histolog
evid
overt
inflammatori
process
despit
conflict
result
presenc
system
level
cytokin
fip
earli
studi
found
high
activ
sera
ascit
fluid
supernat
cultur
periton
exud
cell
cat
fip
howev
mrna
level
peripher
blood
mononuclear
cell
pbmc
found
unalt
mildli
increas
variabl
fip
whilst
transcript
markedli
depress
felin
infecti
periton
fip
coronavirusinduc
fatal
immunemedi
diseas
cat
characteris
serofibrin
granulomat
seros
often
proteinrich
effus
bodi
caviti
granulomat
phlebiti
periphleb
granulomat
inflammatori
lesion
sever
organ
diseas
present
clinic
recurr
fever
sign
reflect
vitro
transcriptom
studi
also
shown
classic
inflammatori
mediat
significantli
alter
felin
infecti
periton
viru
fipv
infect
uninfect
cell
howev
focuss
cell
cultur
experi
use
crfk
cell
may
reflect
complex
immun
interact
vivo
addit
crfk
cell
primari
immun
cell
unlik
exhibit
respons
vitro
studi
use
periton
macrophag
system
closer
diseas
scenario
provid
evid
import
fipv
induc
product
infect
cell
upregul
type
ii
fcov
receptor
aminopeptidas
n
cell
may
thu
enhanc
infect
rate
turn
function
possibl
contributor
lymphocyt
apoptosi
observ
fip
despit
natur
diseas
end
stage
fip
associ
low
increas
case
even
decreas
transcript
lymphat
tissu
conjunct
transcript
show
low
increas
lymphat
tissu
fip
whilst
decreas
remain
unchang
previou
result
suggest
lymphat
tissu
mass
produc
inflammatori
cytokin
level
requir
order
contribut
potenti
system
activ
endotheli
cell
monocyt
organ
system
may
play
role
therefor
first
hypothesis
role
hepatocyt
cytokin
product
alreadi
shown
activ
diseas
cat
fip
hepatocyt
produc
acut
phase
protein
haptoglobin
serum
amyloid
particular
glycoprotein
agp
shown
elev
extent
consid
key
element
diagnost
process
although
thu
far
studi
felin
human
murin
hepatocyt
also
shown
capabl
produc
cytokin
includ
addit
group
previous
identifi
constitut
proinflammatori
cytokin
express
felin
cardiomyocyt
increas
system
inflammatori
diseas
led
second
hypothesi
heart
addit
sourc
cytokin
therebi
contribut
system
inflammatori
statu
allow
fip
lesion
develop
evalu
hypothes
measur
rel
mrna
level
liver
heart
quantit
revers
transcriptas
polymeras
chain
reaction
rtqpcr
use
palett
method
select
case
confirm
translat
identifi
cell
sourc
cytokin
light
previou
find
lymphat
tissu
import
cytokin
determin
balanc
immun
respons
vs
antiinflammatori
also
evalu
hepat
mrna
level
attempt
assess
whether
ratio
correl
clinic
pictur
demonstr
hepatocyt
cardiomyocyt
sourc
inflammatori
cytokin
fip
hepat
balanc
skew
toward
diseas
anim
studi
undertaken
three
group
cat
group
compris
cat
fip
subdivid
natur
infect
pet
cat
age
month
year
group
experiment
infect
four
femal
specif
pathogen
free
spf
cat
age
week
group
see
tabl
cat
submit
diagnost
post
mortem
examin
full
owner
consent
cat
euthanas
fip
experiment
intraperiton
infect
serotyp
fcov
strain
fipvucd
univers
utrecht
netherland
approv
experi
obtain
ethic
committe
utrecht
univers
approv
number
group
cat
show
clinic
sign
fip
necessit
euthanasia
two
cat
week
post
infect
pi
whilst
remain
two
euthanas
end
experi
week
pi
diagnosi
fip
confirm
case
gross
histolog
immunohistolog
examin
six
cat
fip
effus
includ
three
four
experiment
case
data
unavail
three
anim
group
consist
clinic
healthi
male
spf
cat
peror
infect
age
week
previous
isol
serotyp
fcov
field
strain
enter
pathotyp
felin
enter
coronaviru
fecv
euthanas
week
pi
experi
perform
swiss
region
legisl
project
licens
number
tvb
cat
test
posit
fcov
shed
euthanas
week
pi
seroconvert
confirm
system
fcov
infect
presenc
fcov
viraemia
cat
use
comparison
group
provid
rel
uniform
baselin
cytokin
level
pet
cat
without
fip
would
subject
wide
variat
term
pathogen
exposur
fcov
infect
statu
concurr
diseas
also
allow
evalu
effect
fip
anim
rather
fcov
infect
per
se
group
anim
necropsi
within
h
death
liver
sampl
grossli
normal
region
ie
without
fip
lesion
collect
immedi
frozen
c
rna
extract
whilst
normal
lesion
sampl
fix
buffer
formalin
h
routin
paraffin
wax
embed
histolog
immunohistolog
examin
third
group
group
compris
six
healthi
untreat
spf
cat
age
month
euthanas
univers
glasgow
uk
part
studi
perform
uk
home
offic
project
licenc
ppl
cat
formalin
fix
paraffin
embed
liver
sampl
kindli
provid
prof
hosi
studi
undertaken
three
addit
group
cat
group
compris
pet
cat
age
month
year
mean
age
month
die
euthanas
fip
diagnosi
confirm
describ
see
tabl
group
compris
cat
euthanas
due
noninflammatori
diseas
expect
system
impact
month
year
mean
age
year
group
age
group
n
two
group
n
age
year
mean
age
year
acknowledg
fact
age
effect
constitut
cytokin
express
myocardium
see
tabl
group
compris
three
cat
system
inflammatori
diseas
fip
see
tabl
cat
euthanas
submit
diagnost
post
mortem
examin
full
owner
consent
necropsi
within
h
death
pleuriti
involv
outer
pericardium
observ
one
fip
cat
howev
neither
cat
other
exhibit
gross
chang
heart
cat
fip
effus
data
unavail
one
anim
heart
remov
sampl
collect
atria
ventricular
free
wall
interventricular
septum
rnalat
tm
stabil
solut
thermo
fisher
scientif
ilkirch
cedex
franc
store
c
rna
extract
remain
heart
fix
buffer
formalin
h
trim
routin
paraffin
wax
embed
subject
histolog
examin
reveal
patholog
chang
myocardium
cat
frozen
liver
heart
sampl
approxim
mg
taken
rna
extract
subsequ
cdna
synthesi
follow
publish
protocol
liver
rtqpcr
felin
carri
cdna
sampl
use
previous
publish
assay
heart
transcript
assess
mrna
level
housekeep
gene
felin
dehydrogenas
gapdh
serv
intern
control
reaction
run
duplic
use
previous
publish
amplif
condit
assay
composit
briefli
thermal
profil
follow
c
min
c
min
cycl
c
c
min
data
collect
occur
extens
phase
c
perform
proof
principl
singl
fip
cat
heart
group
confirm
cardiomyocyt
respons
detect
mrna
transcript
therefor
subject
statist
analysi
frozen
rnalat
tm
sampl
embed
tissuetek
oct
compound
sakura
finetek
usa
inc
alphen
aan
den
rijn
netherland
cryostat
c
section
onto
pen
membran
glass
slide
appli
waltham
usa
stain
accord
publish
protocol
slide
complet
air
dri
lcm
allow
proper
excis
perform
laser
captur
microdissect
system
thermo
fisher
scientif
arcturu
capsur
macro
lcm
cap
thermo
fisher
scientif
use
lcm
process
area
myocardium
highli
enrich
popul
cardiomyocyt
ie
avoid
small
larg
vessel
adipocyt
identifi
isol
isol
cell
interest
verifi
microscop
examin
lcm
cap
well
excis
region
microdissect
qiagen
rneasi
microkit
qiagen
hilden
germani
use
rna
extract
per
manufactur
protocol
briefli
lcm
cap
place
eppendorf
tube
contain
extract
buffer
incub
invert
c
min
proceed
next
step
final
elut
rna
use
cdna
synthesi
use
superscript
iv
vilo
master
mix
kit
thermo
fisher
scientif
integr
dnase
step
remov
trace
genom
dna
follow
target
specif
preamplif
use
primer
describ
taqman
preamp
master
mix
appli
produc
suffici
cdna
qpcr
analysi
preamplif
perform
accord
manufactur
protocol
use
pcr
cycl
result
product
dilut
use
rtqpcr
reaction
describ
rel
quantif
cytokin
signal
done
compar
threshold
cycl
c
method
use
fgapdh
intern
refer
gene
serv
normalis
differ
virus
amount
total
nucleic
acid
ad
reaction
effici
revers
transcriptas
step
programm
ibm
spss
use
statist
comparison
twotail
mannwhitney
test
appli
confid
level
premis
cytokin
level
two
group
differ
liver
studi
first
natur
fip
case
group
compar
experiment
fip
case
group
determin
could
class
one
group
statist
signific
differ
found
subgroup
group
compar
group
group
also
compar
separ
group
within
group
cytokin
mrna
level
cat
without
effus
compar
diseas
form
subgroup
fip
cat
compar
control
cat
clinic
inform
regard
presenc
effus
lack
individu
exclud
comparison
mrna
ratio
evalu
use
independ
sampl
median
test
heart
studi
cat
fip
group
compar
control
cat
group
cat
system
inflammatori
diseas
group
take
potenti
age
influenc
account
fip
cat
cat
system
diseas
subsequ
compar
young
group
old
group
control
cat
within
group
fip
case
split
without
effus
first
compar
separ
control
cat
age
subgroup
control
cat
cat
system
inflammatori
diseas
sinc
antibodi
react
felin
cytokin
interest
avail
panel
rabbit
antipeptid
antibodi
specif
felin
commerci
produc
genospher
biotechnolog
pari
franc
antibodi
rais
cterminu
protein
use
amino
acid
long
synthet
peptid
addit
cystein
residu
nterminu
coupl
keyhol
limpet
hemocyanin
klh
carrier
see
supplement
tabl
antisera
determin
supplier
elisa
titr
greater
test
peptid
antigen
antibodi
specif
confirm
elisa
dot
blot
use
recombin
cytokin
avail
human
peprotech
london
uk
felin
serotec
biorad
oxford
uk
felin
r
system
zug
switzerland
follow
routin
protocol
immunoblot
also
perform
follow
routin
protocol
homogenis
liver
sampl
experiment
fip
cat
confirm
reaction
nativ
protein
antibodi
subsequ
use
immunohistolog
specif
could
confirm
western
blot
system
mous
monoclon
antibodi
direct
felin
r
system
becam
commerci
avail
follow
complet
initi
liver
studi
test
small
set
liver
sampl
antibodi
previous
publish
serv
confirm
protein
express
myocardium
stain
protocol
antipeptid
antibodi
optimis
use
fip
lesion
diagnost
case
mix
inflammatori
cell
popul
present
stain
appli
select
case
five
cat
group
four
cat
group
cat
group
liver
studi
briefli
formalinfix
paraffin
embed
liver
section
subject
immunohistolog
stain
follow
previous
publish
peroxidas
antiperoxidas
pap
method
diaminobenzidin
chromogen
papanicola
haematoxylin
counterstain
section
incub
rabbit
preimmun
serum
andor
pb
instead
primari
antibodi
section
incub
antibodi
block
respect
peptid
serv
neg
control
yield
reaction
stain
liver
section
assess
independ
two
pathologist
ajm
ak
stain
grade
semiquantit
heart
studi
formalinfix
paraffin
embed
section
left
right
ventricular
free
wall
atrium
interventricular
septum
stain
use
commerci
antibodi
see
custommad
antibodi
longer
avail
time
briefli
protocol
follow
pretreat
citrat
buffer
follow
min
serum
block
incub
primari
antibodi
dilut
dilut
buffer
dako
basel
switzerland
room
temperatur
h
use
envis
mous
dako
cytom
detect
system
chromogen
counterstain
method
control
describ
hepat
transcript
test
cytokin
detect
group
major
anim
cytokin
depend
tabl
rel
transcript
level
cytokin
significantli
higher
p
cat
fip
variat
anim
observ
group
greater
fip
group
figur
latter
within
group
variat
cytokin
lower
experiment
infect
group
natur
infect
group
transcript
level
overal
though
significantli
tabl
compar
natur
experiment
infect
cat
fip
separ
fecvinfect
healthi
cat
signific
differ
observ
experiment
infect
anim
fip
transcrib
higher
level
cat
fip
figur
tabl
mrna
ratio
assess
accept
indic
inflammatori
balanc
immun
system
overal
significantli
higher
cat
fip
p
indic
balanc
tip
toward
proinflammatori
state
fact
level
higher
level
individu
control
cat
wherea
half
natur
infect
fip
cat
level
lower
level
experiment
fip
cat
group
slightli
higher
level
anim
show
largest
quantit
differ
median
cat
without
fip
mrna
level
nearli
fold
higher
diseas
interestingli
owe
lower
rel
transcript
level
healthi
cat
cytokin
though
differ
statist
signific
wherea
cat
fip
level
par
cytokin
also
cytokin
vari
depend
presenc
absenc
effus
transcript
significantli
higher
p
cat
effus
without
tabl
close
fold
increas
rel
transcript
seen
cat
without
diseas
whilst
smallest
quantit
differ
found
cytokin
mrna
level
fold
higher
fip
immunohistolog
use
identifi
cell
sourc
cytokin
spf
cat
liver
histolog
unalt
serv
assess
fcovindepend
constitut
protein
express
cytokin
express
mainli
evid
bile
duct
epithelium
exhibit
variabl
express
cytokin
figur
also
occasion
evid
ie
one
two
anim
cytokin
low
level
express
hepatocyt
repres
weak
fine
granular
cytoplasm
stain
figur
furthermor
kupffer
cell
spf
cat
occasion
express
two
one
cat
respect
also
figur
liver
fcovinfect
cat
without
fip
often
exhibit
mild
portal
lymphocyt
infiltr
well
occasion
small
cluster
lymphocyt
scatter
individu
neutrophil
within
sinusoid
cytokin
express
pattern
intens
similar
seen
spf
cat
hepatocyt
larg
exhibit
either
weak
stain
cat
fip
major
liver
exhibit
typic
lesion
ie
fibrinosuppur
perihepat
andor
focal
multifoc
granulomatousnecrotis
inflamm
cytokin
express
inflammatori
cell
gener
weak
cytokin
found
express
macrophag
neutrophil
well
low
number
kupffer
cell
figur
hepatocyt
shown
express
cytokin
seen
either
diffus
stain
hepatocyt
figur
h
j
appear
vari
intens
individu
cell
figur
direct
correl
protein
express
mrna
level
observ
semiquantit
assess
cytokin
express
perihepat
andor
focal
multifoc
granulomatousnecrotis
inflamm
cytokin
express
inflammatori
cell
gener
weak
cytokin
found
express
macrophag
neutrophil
well
low
number
kupffer
cell
figur
hepatocyt
shown
express
cytokin
seen
either
diffus
stain
hepatocyt
figur
h
j
appear
vari
intens
individu
cell
figur
direct
correl
protein
express
mrna
level
observ
semiquantit
assess
cytokin
express
constitut
transcrib
heart
cat
fip
exhibit
significantli
higher
myocardi
p
p
transcript
control
cat
control
cat
split
age
older
cat
retain
signific
differ
three
cytokin
p
wherea
significantli
lower
young
control
cat
cat
fip
tabl
signific
differ
cat
system
inflammatori
diseas
fip
cat
fip
without
effus
fip
subgroup
without
effus
compar
turn
group
result
almost
ident
obtain
use
combin
fip
group
except
compar
fip
cat
without
effus
control
significantli
differ
despit
combin
fip
group
fip
cat
effus
show
significantli
higher
transcript
level
control
display
graphic
figur
data
distribut
summaris
tabl
laser
captur
microdissect
sampl
myocardium
demonstr
mrna
express
cardiomyocyt
stain
repres
select
heart
sampl
cat
fip
confirm
product
predominantli
cardiomyocyt
endotheli
cell
smooth
muscl
cell
laser
captur
microdissect
sampl
myocardium
demonstr
mrna
express
cardiomyocyt
stain
repres
select
heart
sampl
cat
fip
confirm
product
predominantli
cardiomyocyt
endotheli
cell
smooth
muscl
cell
tunica
media
also
posit
section
mesotheli
cell
show
irregular
stain
present
first
function
studi
kind
focu
potenti
contribut
nonimmun
organ
ie
liver
heart
cytokin
product
cat
affect
fip
gener
system
inflammatori
diseas
per
se
specif
panel
cytokin
well
chosen
base
known
effect
assess
potenti
role
diseas
manifest
fip
driven
activ
monocyt
characteris
vascular
inflammatori
lesion
fever
use
combin
method
demonstr
cytokin
transcript
situ
protein
express
well
could
show
organ
produc
entir
panel
proinflammatori
immunomodulatori
cytokin
confirm
parenchym
cell
hepatocyt
cardiomyocyt
sourc
vari
origin
differ
group
cat
reflect
avail
tissu
sampl
studi
aim
maximis
inform
glean
previou
unrel
experiment
infect
case
collect
utilis
tissu
tackl
hypothes
result
obtain
liver
studi
provid
springboard
studi
heart
retrospect
sampl
avail
present
togeth
felt
combin
result
add
knowledg
potenti
pathogenesi
cours
come
limit
intergroup
match
henc
drawn
broad
rather
highli
specif
conclus
group
compar
organ
liver
low
level
express
observ
healthi
fcovinfect
cat
whilst
transcript
significantli
upregul
fip
interestingli
compar
natur
experiment
fip
rang
cytokin
transcript
extend
higher
natur
case
possibl
prior
spf
statu
experiment
infect
cat
account
would
previou
exposur
fcov
andor
common
infecti
pathogen
would
also
regul
stage
diseas
receiv
ident
viru
dosag
like
explain
lower
variabl
result
differ
group
higher
level
mani
natur
case
also
support
role
organ
system
inflamm
gener
rather
fcov
specif
respons
cat
fip
hepatocyt
also
inflammatori
cell
within
typic
macrophag
domin
lesion
found
unsurprisingli
express
examin
cytokin
howev
inflammatori
cell
like
play
minor
role
overal
hepat
transcript
sinc
extract
rna
tissu
specimen
without
grossli
visibl
fip
lesion
gener
found
immunohistolog
evid
consist
cytokin
express
hepatocyt
inflammatori
cell
differ
antibodi
show
variat
stain
pattern
either
rel
diffus
show
vari
intens
hepatocyt
precis
caus
unknown
may
reflect
variat
cytokin
express
releas
beyond
scope
studi
heart
affect
fip
lesion
case
consist
known
lesion
distribut
despit
pyrogen
cytokin
upregul
fip
also
seen
system
inflammatori
diseas
like
affect
heart
similar
way
cardiomyocyt
confirm
sourc
cytokin
mrna
protein
find
suggest
bystand
cell
cardiomyocyt
hepatocyt
like
play
signific
role
amplifi
system
inflamm
respond
nonspecif
inflammatori
process
immunohistolog
stain
result
allow
accur
quantif
translat
could
identifi
direct
correl
mrna
protein
level
number
possibl
explanationsth
differ
region
sampl
differ
sensit
two
method
time
laps
transcript
translat
sampl
taken
singl
time
point
manifold
level
preand
posttransl
regul
cytokin
expos
take
alon
regul
mrna
export
posttranscript
translat
multipl
mechan
stage
howev
object
confirm
rather
quantifi
parenchym
cytokin
express
togeth
known
cytokin
function
result
provid
strong
evid
hepatocyt
cardiomyocyt
may
inde
play
role
system
inflammatori
diseas
henc
pathogenesi
fip
support
data
mous
studi
show
hepatocyt
produc
least
much
per
cell
macrophag
tradit
thought
reactiv
even
bystand
role
diseas
parenchym
cell
may
fact
provid
larg
amplifi
step
cascad
cytokin
releas
role
howev
secondari
rather
unspecif
system
inflammatori
diseas
found
associ
myocardi
transcript
level
similar
seen
cat
fip
whether
organ
lung
resid
macrophag
pulmonari
intravascular
macrophag
may
target
fcov
also
role
play
remain
investig
major
inflammatori
cytokin
cat
fip
link
lesion
induct
clinic
sign
fever
may
also
contribut
hypoalbuminaemia
weight
loss
seen
fip
via
decreas
albumin
product
increas
muscl
breakdown
respect
adhes
molecul
express
chemokin
product
endotheli
cell
ec
induc
lead
leukocyt
bind
line
upregul
seen
leukocyt
cat
fip
cytokin
expect
contribut
destruct
vascular
basal
lamina
seen
fip
phlebiti
upregul
matrix
metalloproteinas
secret
monocyt
known
particularli
stimul
show
greatest
hepat
upregul
studi
cytokin
associ
fip
one
significantli
higher
effus
form
diseas
compar
noneffus
form
wet
fip
signific
activ
previous
report
sera
periton
exud
cell
wet
dri
mix
form
fip
indic
overlap
diseas
state
variabl
degre
vascular
permeabl
induc
vascular
endotheli
growth
factor
vegf
product
pulmonari
vascular
permeabl
degre
ascit
found
correl
serum
vegf
level
cat
fip
could
explain
via
vegf
upregul
particularli
high
hepat
transcript
level
seen
fip
cat
effus
studi
hepat
releas
could
also
contribut
progress
plasma
cell
infiltr
seen
older
fip
lesion
induc
final
matur
b
cell
plasma
cell
might
also
influenc
myocardi
cytokin
transcript
show
lower
increas
fip
compar
control
cat
liver
sampl
might
therefor
suggest
later
reactiv
involv
myocardium
diseas
process
show
reactiv
respons
might
also
reason
differ
myocardi
transcript
observ
effus
noneffus
form
fip
howev
investig
time
cours
fipv
infect
need
interestingli
shown
experiment
doubl
halflif
mrna
similar
less
intens
effect
accordingli
addit
direct
effect
could
two
relev
synergist
effect
fip
stimul
transcript
prolong
lifespan
mrna
therebi
potenti
effect
similar
mrna
concentr
myocardium
young
control
cat
cat
fip
confirm
previou
find
gener
reactiveinflammatori
myocardium
young
cat
might
also
contribut
increas
suscept
young
cat
fip
subsequ
amplifi
inflammatori
process
antiinflammatori
immunosuppress
cytokin
inhibit
inflammatori
cytokin
transcript
monocyt
also
complement
stimul
antibodi
product
host
attempt
counteract
proinflammatori
signal
fip
increas
express
may
therefor
neg
side
effect
promot
antifcov
antibodi
product
also
found
upregul
liver
associ
fip
proinflammatori
effect
usual
counteract
attempt
return
immun
respons
homeostat
base
level
ratio
use
measur
balanc
proand
antiinflammatori
state
number
diseas
condit
studi
found
overal
higher
hepat
mrna
ratio
fip
healthi
fcovinfect
cat
despit
archetyp
proinflammatori
high
concentr
inhibit
immun
respons
gener
cytotox
lymphocyt
contrast
liver
mesenter
lymph
node
previous
found
downregul
transcript
fip
level
unaffect
would
appear
neither
high
high
protect
inde
plasmid
encod
found
enhanc
suscept
diseas
fipv
vaccin
studi
rather
offer
protect
predict
studi
shed
light
contribut
nonimmun
organ
specif
heart
liver
system
diseas
directli
target
knowledg
help
bridg
gap
accept
understand
fip
immunemedi
inflammatori
diseas
seemingli
limit
contribut
primari
immun
organ
inflammatori
cytokin
product
also
provid
avenu
studi
role
organ
felin
system
diseas
supplementari
materi
follow
avail
onlin
http
tabl
amino
acid
sequenc
use
antifelin
cytokin
antibodi
product
tabl
distribut
statist
liver
studi
group
tabl
distribut
statist
heart
studi
group
